Herbal Evaluation Of Artemisia Annua For Small Intestinal Bacterial Overgrowth

Trial statusRecruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorNational University of Natural Medicine

About this trial

Small intestinal bacterial overgrowth (SIBO) can cause symptoms like bloating, stomach pain, and changes in bowel movements, significantly affecting quality of life. Many people with irritable bowel syndrome (IBS) also have SIBO, and there is growing recognition of how important it is to address this condition. Artemisia annua has shown potential in managing SIBO based on early reports and studies suggesting it can fight bacteria like \*E. coli\* and \*Klebsiella\*, which are linked to a type of SIBO that produces hydrogen gas.

This study aims to test if Artemisia annua is safe and well-tolerated for adults with hydrogen-type SIBO. Over five weeks, participants will take either 5 grams of dried Artemisia annua leaves or a placebo. Researchers will monitor safety through blood tests, vital signs, and adverse events, and they will assess symptom changes using questionnaires and breath tests.

The trial will include up to 32 participants from the Portland, Oregon area. Participants will be randomly assigned to treatment groups, and neither they, the researchers, nor the test administrators will know who is receiving the herb or the placebo. Results will be analyzed using standard statistical methods.

This study addresses the lack of research on herbal treatments for SIBO. If successful, the findings could lead to larger studies and help expand treatment options for people with SIBO.

Eligibility criteria

Qualifiers

Adults 18 years of age or older

IBS-SSS score >175

Meets North American Consensus criteria for H2 SIBO

Willing to take Artecinua™ or placebo as a dietary supplement for 5 weeks

Disqualifiers

Use of antibiotic pharmaceuticals or supplements 14 days before baseline breath test

Initiation of change in diet, medication, or supplement regime within 30 days

Hospitalization within the past 3 months

Women who are breastfeeding, pregnant, or planning pregnancy in the next 4 months

Trial design

Treatments tested in this trial

  • Artemisia Annua Leaf
  • placebo

Treatment groups

32 Participants
are divided into 2 treatment groups

Sponsors and collaborators